• Return to Headlines

Bio-Rad Laboratories: 52-Week High Recently Eclipsed (BIO)

By David Diaz

Shares of Bio-Rad Laboratories (NYSE:BIO) traded at a new 52-week high today of $203.39. This new high was reached on approximately average trading volume as 103,000 shares traded hands, while the average 30-day volume is approximately 110,000 shares.

In the past 52 weeks, shares of Bio-Rad Laboratories have traded between a low of $122.03 and a high of $203.39 and are now at $201.70, which is 65% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.7% while the 200-day MA has remained constant.

Bio-Rad Laboratories, Inc. is a multinational manufacturer and distributor of life science research products, clinical diagnostics, and analytical instrumentation. The Company's products and systems separate complex chemical and biological materials, as well as identify, analyze, and purify their components.

Potential upside of 5.8% exists for Bio-Rad Laboratories, based on a current level of $201.70 and analysts' average consensus price target of $213.33. The stock should find initial support at its 50-day moving average (MA) of $137.93 and further support at its 200-day MA of $137.52.

SmarTrend recommended that subscribers consider buying shares of Bio-Rad Laboratories on July 12th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $144.77. Since that recommendation, shares of Bio-Rad Laboratories have risen 36.5%. We continue to monitor BIO for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows bio-rad laboratories

Ticker(s): BIO